- Media
Prima Bhd (MPR MK) | Company Update
- Filinvest
Land Inc. (FLI PM) | Results Review
- Philippine
National Bank (PNB PM) | Results Review
- Sino
Grandness (SFGI SP) | Company Update
- Genting
Singapore (GENS SP) | Results Review
- Courts
Asia (COURTS SP) | Company Update
- AP
(Thailand) (AP TB) | Company Update
- Bangkok
Dusit Medical Services (BGH TB) | Results Review
- CH.
Karnchang (CK TB) | Results Review
- Italian-Thai
Development (ITD TB) | Results Review
|
Media Prima Bhd (MPR MK)
|
Washout quarter
|
Share Price: MYR2.39 | Target
Price: MYR2.16(-10%) | MCap (USD): 826M | ADTV (USD): 1.0M
|
- MPR�s 2Q14 results were below
expectations � 1H14
adex at every segment fell YoY, save for two.
- Adex
should recover in 2H14 as consumers are cajoled into
purchasing durable goods before GST.
- Maintain
HOLD but lower TP by 15% to MYR2.16.
|
Filinvest Land Inc. (FLI PM)
|
Sustained project roll-out
|
Share Price: PHP1.53 | Target
Price: PHP2.50 (+63%) | MCap (USD): 846M | ADTV (USD): 0.6M
|
- Net
income grew 14.8% YoY in 1H14 driven by stronger real estate
sales and rental incomes.
- Slight
GPM erosion but we expect improvement once project launches
for middle-income segment is booked.
- Maintain
BUY and TP of PHP2.50 as we expect stronger performance in
2H14 due to commercial operations of new offices and
additional project launches.
- (FULL
REPORT WILL BE OUT SOON)
|
Philippine National Bank (PNB PM)
|
Better treasury boosts earnings
|
Share Price: PHP90.00 | Target
Price: PHP109.00 (+21%) | MCap (USD): 2.6B | ADTV (USD): 1M
|
- Still
a BUY with 21% upside to TP of PHP109, at 1.5x PBV.
- 1H14
earnings beat our expectations on better trading gains.
- Remains
an attractive acquisition target.
- (FULL
REPORT WILL BE OUT SOON)
|
Sino Grandness (SFGI SP)
|
Wait for more clarity
|
Share Price: SGD0.75 | Target
Price: SGD0.76(+2%) | MCap (USD): 351M | ADTV (USD): 1.0M
|
- Prospective
investor in talks with company to acquire substantial stake.
- Short-term
positive. Could ease market jitters over liquidity.
- Not
over-excited pending details. Maintain HOLD and TP of SGD0.76.
|
Genting Singapore (GENS SP)
|
Caught the China cold
|
Share Price: SGD1.28 | Target
Price: SGD1.24 (-3%) | MCap (USD): 12.5B | ADTV (USD): 10M
|
- 2Q14
results were within expectations. That said, 2Q14 VIP volume
fell sharply QoQ and bad debts hit a new high.
- Expect
future quarters to continue to be weak due to continued tight
credit conditions in China.
- Our
estimates are little changed. Maintain HOLD with an unchanged
TP of SGD1.24 on 10x FY14E EV/EBITDA.
- (FULL
REPORT WILL BE OUT SOON)
|
Courts Asia (COURTS SP)
|
No improvement yet
|
Share Price: SGD0.52 | Target
Price: SGD0.60 (+15%) | MCap (USD): 233M | ADTV (USD): 0.1M
|
- Coverage
transferred to Truong Thanh Hang. The retail environment in
Singapore and Malaysia is still lacklustre, due to poor
consumer sentiment.
- Bottom-line
further hit by rising expenses partially linked to Courts� expansion throughout the
region
- Expansion
strategy in Indonesia with opening of three stores by
end-FY3/15. However, Courts expects to turn a profit only from
2016. Maintain HOLD.
- (FULL
REPORT WILL BE OUT SOON)
|
AP (Thailand) (AP TB)
|
Strong presales support rerating
|
Share Price: THB7.20 | Target
Price: THB8.00 (+11%) | MCap (USD): 644M | ADTV (USD): 5M
|
- Maintain
BUY and raise TP of our sector top pick to THB8.0 (from
THB7.5) following earnings adjustment of 5.3 in FY14 and 6.0%
in FY15.
- 2Q14
net profit was up 174% QoQ and 57% YoY to THB712m (EPS
THB0.25), beating our and Bloomberg consensus forecasts by 11%
and 18%.
- AP
raises revenue target to THB22b (from THB21b), in line with
our forecast, after seeing good momentum and record-high landed
property sales.
|
Bangkok Dusit Medical Services
(BGH TB)
|
Within expectation, strong ahead
|
Share Price: THB18.80 | Target
Price: THB22.00 (+17%) | MCap (USD): 9.1B | ADTV (USD): 23M
|
- Earnings
in-line with our and market expectation. 1H14 sales and
earnings accounted for 48%/51% of our FY14 estimates vs.
49%/52% in 1H13 and 48%/50% for consensus.
- 2Q14
sales/NPAT increased 9%/7% YoY, bringing 1H14 sales/NPAT
growth to 11%/7% YoY. EBITDA up 20% YoY with margin at 19.6%
(+166bps) thanks to cost control measures.
- Maintain
BUY with DCF-based TP of THB22, implying 37x PER, 6x PB/V, and
1.3x PEG for 2015F. Medium to long-term outlook remain solid.
Short-term also strong.
|
CH. Karnchang (CK TB)
|
2Q14: Beat estimates
|
Share Price: THB27.25 | Target
Price: THB32.00 (+17%) | MCap (USD): 1.4B | ADTV (USD): 36M
|
- Reiterate
BUY with SOTP-based TP of THB32; expect CK to have the most
new projects signed this year and bright outlook for its
listed subsidiaries to support further re-rating.
- 2Q14
earnings of THB312m (EPS THB0.18) beat our estimates (THB151m)
and Bloomberg consensus (THB265m) due to significant
lower-than-expected interest expenses.
- Maintain
positive outlook on the construction industry. Bidding on
projects worth THB86b should start in 4Q14 (Dark Green Line,
Double Track and Suvarnabhumi Phase II).
|
Italian-Thai Development (ITD TB)
|
Bright outlook offset weak result
|
Share Price: THB5.20 | Target
Price: THB6.00 (+15%) | MCap (USD): 790M | ADTV (USD): 24M
|
- Maintain
BUY, TP THB6.0 based on 2.4x PBV in FY14; Prime beneficiary
from upcoming infrastructure investment. Bright prospects on
the construction industry outweigh weak results.
- 2Q14
net profit was at THB50m (EPS THB0.01), down 68% QoQ and 44%
YoY, below our and Bloomberg consensus estimates by 71%.
- Expect
continuous positive news flow for the construction industry
which is a key share price catalyst.
|
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.